U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Congenital generalized lipodystrophy

MedGen UID:
67438
Concept ID:
C0221032
Disease or Syndrome; Finding
Synonym: Congenital generalized lipodystrophy (disease)
SNOMED CT: Lawrence syndrome (86907008); Lipoatrophic diabetes mellitus (284449005); Total lipoatrophy (284449005); Berardinelli-Seip congenital lipodystrophy (284449005); Congenital generalized lipodystrophy (284449005); Beradinelli-Seip syndrome (284449005); Berardinelli's syndrome (284449005); Lawrence-Seip syndrome (284449005); Seip's syndrome (284449005); Congenital total lipodystrophy (284449005)
 
Related genes: CAVIN1, BSCL2, AGPAT2, CAV1
 
HPO: HP:0009059
Monarch Initiative: MONDO:0006536
OMIM® Phenotypic series: PS608594

Disease characteristics

Excerpted from the GeneReview: Berardinelli-Seip Congenital Lipodystrophy
Berardinelli-Seip congenital lipodystrophy (BSCL) is usually diagnosed at birth or soon thereafter. Because of the absence of functional adipocytes, lipid is stored in other tissues, including muscle and liver. Affected individuals develop insulin resistance and approximately 25%-35% develop diabetes mellitus between ages 15 and 20 years. Hepatomegaly secondary to hepatic steatosis and skeletal muscle hypertrophy occur in all affected individuals. Hypertrophic cardiomyopathy is reported in 20%-25% of affected individuals and is a significant cause of morbidity from cardiac failure and early mortality. [from GeneReviews]
Authors:
Lionel Van Maldergem   view full author information

Additional description

From MedlinePlus Genetics
Congenital generalized lipodystrophy (also called Berardinelli-Seip congenital lipodystrophy) is a rare condition characterized by an almost total lack of fatty (adipose) tissue in the body and a very muscular appearance. Adipose tissue is found in many parts of the body, including beneath the skin and surrounding the internal organs. It stores fat for energy and also provides cushioning. Congenital generalized lipodystrophy is part of a group of related disorders known as lipodystrophies, which are all characterized by a loss of adipose tissue. A shortage of adipose tissue leads to the storage of fat elsewhere in the body, such as in the liver and muscles, which causes serious health problems.

The signs and symptoms of congenital generalized lipodystrophy are usually apparent from birth or early childhood. One of the most common features is insulin resistance, a condition in which the body's tissues are unable to recognize insulin, a hormone that normally helps to regulate levels of blood glucose, also called blood sugar. Insulin resistance may develop into a more serious disease called diabetes mellitus. Most affected individuals also have high levels of fats called triglycerides circulating in the bloodstream (hypertriglyceridemia), which can lead to the development of small yellow deposits of fat under the skin called eruptive xanthomas and inflammation of the pancreas (pancreatitis). Additionally, congenital generalized lipodystrophy causes an abnormal buildup of fats in the liver (hepatic steatosis), which can result in an enlarged liver (hepatomegaly) and liver failure. Some affected individuals develop a form of heart disease called hypertrophic cardiomyopathy, which can lead to heart failure and an abnormal heart rhythm (arrhythmia) that can cause sudden death.

People with congenital generalized lipodystrophy have a distinctive physical appearance. They appear very muscular because they have an almost complete absence of adipose tissue and an overgrowth of muscle tissue. A lack of adipose tissue under the skin also makes the veins appear prominent. Affected individuals tend to have prominent bones above the eyes (orbital ridges), large hands and feet, and a prominent belly button (umbilicus). Affected females may have an enlarged clitoris (clitoromegaly), an increased amount of body hair (hirsutism), irregular menstrual periods, and multiple cysts on the ovaries, which may be related to hormonal changes. Many people with this disorder develop acanthosis nigricans, a skin condition related to high levels of insulin in the bloodstream. Acanthosis nigricans causes the skin in body folds and creases to become thick, dark, and velvety.

Researchers have described four types of congenital generalized lipodystrophy, which are distinguished by their genetic cause. The types also have some differences in their typical signs and symptoms. For example, in addition to the features described above, some people with congenital generalized lipodystrophy type 1 develop cysts in the long bones of the arms and legs after puberty. Type 2 can be associated with intellectual disability, which is usually mild to moderate. Type 3 appears to cause poor growth and short stature, along with other health problems. Type 4 is associated with muscle weakness, delayed development, joint abnormalities, a narrowing of the lower part of the stomach (pyloric stenosis), and severe arrhythmia that can lead to sudden death.  https://medlineplus.gov/genetics/condition/congenital-generalized-lipodystrophy

Conditions with this feature

Lipodystrophy-intellectual disability-deafness syndrome
MedGen UID:
334166
Concept ID:
C1842465
Disease or Syndrome
Lipodystrophy-intellectual disability-deafness syndrome is an extremely rare form of genetic lipodystrophy (see this term), reported in 3 patients from one family to date, characterized by generalized congenital lipodystrophy, low birth weight, progressive sensorineural deafness occurring in childhood, intellectual deficit, progressive osteopenia, delayed skeletal maturation, skeletal abnormalities described as slender, undermineralized tubular bones, and dense metaphyseal striations in the distal femur, ulna and radius of older patients. Autosomal recessive inheritance has been suggested.

Professional guidelines

PubMed

Gupta N, Asi N, Farah W, Almasri J, Barrionuevo P, Alsawas M, Wang Z, Haymond MW, Brown RJ, Murad MH
J Clin Endocrinol Metab 2017 Feb 1;102(2):363-374. doi: 10.1210/jc.2016-2271. PMID: 27967300Free PMC Article
Jéru I, Vatier C, Araujo-Vilar D, Vigouroux C, Lascols O
Eur J Hum Genet 2016 Nov;24(11) Epub 2016 May 18 doi: 10.1038/ejhg.2016.53. PMID: 27189019Free PMC Article
Agarwal AK, Garg A
Annu Rev Med 2006;57:297-311. doi: 10.1146/annurev.med.57.022605.114424. PMID: 16409151

Recent clinical studies

Etiology

Yildirim Simsir I, Tuysuz B, Ozbek MN, Tanrikulu S, Celik Guler M, Karhan AN, Denkboy Ongen Y, Gunes N, Soyaltin UE, Altay C, Nur B, Ozalkak S, Akgun Dogan O, Dursun F, Pekkolay Z, Eren MA, Usta Y, Ozisik S, Ozgen Saydam B, Adiyaman SC, Unal MC, Gungor Semiz G, Turan I, Eren E, Kayserili H, Jeru I, Vigouroux C, Atik T, Onay H, Ozen S, Arioglu Oral E, Akinci B
Diabetes Obes Metab 2023 Jul;25(7):1950-1963. Epub 2023 Apr 11 doi: 10.1111/dom.15061. PMID: 36946378
Patni N, Garg A
Curr Diab Rep 2022 Sep;22(9):461-470. Epub 2022 Jul 11 doi: 10.1007/s11892-022-01485-w. PMID: 35821558Free PMC Article
Mainieri F, Tagi VM, Chiarelli F
Front Endocrinol (Lausanne) 2022;13:879979. Epub 2022 May 4 doi: 10.3389/fendo.2022.879979. PMID: 35600578Free PMC Article
Sorkina E, Chichkova V
Presse Med 2021 Nov;50(3):104075. Epub 2021 Sep 22 doi: 10.1016/j.lpm.2021.104075. PMID: 34562560
Hsu RH, Lin WD, Chao MC, Hsiao HP, Wong SL, Chiu PC, Chu SY, Ke YY, Lau BH, Chien YH, Hwu WL, Tsai FJ, Wang CH, Lee NC
J Formos Med Assoc 2019 Jan;118(1 Pt 1):142-147. Epub 2018 Mar 1 doi: 10.1016/j.jfma.2018.02.003. PMID: 29478747

Diagnosis

Patni N, Garg A
Curr Diab Rep 2022 Sep;22(9):461-470. Epub 2022 Jul 11 doi: 10.1007/s11892-022-01485-w. PMID: 35821558Free PMC Article
Sorkina E, Chichkova V
Presse Med 2021 Nov;50(3):104075. Epub 2021 Sep 22 doi: 10.1016/j.lpm.2021.104075. PMID: 34562560
Hsu RH, Lin WD, Chao MC, Hsiao HP, Wong SL, Chiu PC, Chu SY, Ke YY, Lau BH, Chien YH, Hwu WL, Tsai FJ, Wang CH, Lee NC
J Formos Med Assoc 2019 Jan;118(1 Pt 1):142-147. Epub 2018 Mar 1 doi: 10.1016/j.jfma.2018.02.003. PMID: 29478747
Prieur X, Le May C, Magré J, Cariou B
Curr Atheroscler Rep 2014 Sep;16(9):437. doi: 10.1007/s11883-014-0437-x. PMID: 25047893
Garg A
Am J Med 2000 Feb;108(2):143-52. doi: 10.1016/s0002-9343(99)00414-3. PMID: 11126308

Therapy

Altarejos JY, Pangilinan J, Podgrabinska S, Akinci B, Foss-Freitas M, Neidert AH, Ray Y, Zheng W, Kim S, Kamat V, Huang M, Min S, Mastaitis J, Dominguez-Gutierrez G, Kim JH, Stevis P, Huang T, Zambrowicz B, Olson WC, Godin S, Bradley E, Gewitz AD, Baker M, Hench R, Davenport MS, Chenevert TL, DiPaola F, Yancopoulos GD, Murphy AJ, Herman GA, Musser BJ, Dansky H, Harp J, Gromada J, Sleeman MW, Oral EA, Olenchock BA
Sci Transl Med 2023 Nov 22;15(723):eadd4897. doi: 10.1126/scitranslmed.add4897. PMID: 37992152
Patni N, Garg A
Curr Diab Rep 2022 Sep;22(9):461-470. Epub 2022 Jul 11 doi: 10.1007/s11892-022-01485-w. PMID: 35821558Free PMC Article
Mainieri F, Tagi VM, Chiarelli F
Front Endocrinol (Lausanne) 2022;13:879979. Epub 2022 May 4 doi: 10.3389/fendo.2022.879979. PMID: 35600578Free PMC Article
Cook K, Ali O, Akinci B, Foss de Freitas MC, Montenegro RM, Fernandes VO, Gupta D, Lou KJ, Tuttle E, Oral EA, Brown RJ
J Clin Endocrinol Metab 2021 Jul 13;106(8):e2953-e2967. doi: 10.1210/clinem/dgab216. PMID: 33822100Free PMC Article
Tchang BG, Shukla AP, Aronne LJ
Expert Opin Biol Ther 2015 Jul;15(7):1061-75. doi: 10.1517/14712598.2015.1052789. PMID: 26063386

Prognosis

Fernández-Pombo A, Sánchez-Iglesias S, Castro-Pais AI, Ginzo-Villamayor MJ, Cobelo-Gómez S, Prado-Moraña T, Díaz-López EJ, Casanueva FF, Loidi L, Araújo-Vilar D
Front Endocrinol (Lausanne) 2023;14:1250203. Epub 2023 Nov 16 doi: 10.3389/fendo.2023.1250203. PMID: 38034001Free PMC Article
Su X, Lin Y, Liu L, Mei H, Xu A, Zeng C, Sheng H, Cheng J, Shao Y, Zheng R, Ting TH, Zhang W, Li X
J Pediatr Endocrinol Metab 2023 Jan 27;36(1):74-80. Epub 2022 Nov 28 doi: 10.1515/jpem-2022-0372. PMID: 36433712
Hsu RH, Lin WD, Chao MC, Hsiao HP, Wong SL, Chiu PC, Chu SY, Ke YY, Lau BH, Chien YH, Hwu WL, Tsai FJ, Wang CH, Lee NC
J Formos Med Assoc 2019 Jan;118(1 Pt 1):142-147. Epub 2018 Mar 1 doi: 10.1016/j.jfma.2018.02.003. PMID: 29478747
Huang L, Shi H, Zhou X
Endocr Pract 2017 Jul;23(7):857-862. Epub 2017 Apr 27 doi: 10.4158/EP161686.RA. PMID: 28448764
Seip M, Trygstad O
Acta Paediatr Suppl 1996 Jun;413:2-28. doi: 10.1111/j.1651-2227.1996.tb14262.x. PMID: 8783769

Clinical prediction guides

Fernández-Pombo A, Sánchez-Iglesias S, Castro-Pais AI, Ginzo-Villamayor MJ, Cobelo-Gómez S, Prado-Moraña T, Díaz-López EJ, Casanueva FF, Loidi L, Araújo-Vilar D
Front Endocrinol (Lausanne) 2023;14:1250203. Epub 2023 Nov 16 doi: 10.3389/fendo.2023.1250203. PMID: 38034001Free PMC Article
Qannan A, Bejaoui Y, Izadi M, Yousri NA, Razzaq A, Christiansen C, Martin GM, Bell JT, Horvath S, Oshima J, Megarbane A, Ericsson J, Pourkarimi E, El Hajj N
Hum Mol Genet 2023 May 18;32(11):1826-1835. doi: 10.1093/hmg/ddad016. PMID: 36715159Free PMC Article
Santos JL, Cortés VA
Obes Rev 2021 Jan;22(1):e13114. Epub 2020 Aug 2 doi: 10.1111/obr.13114. PMID: 33030294
Gupta N, Asi N, Farah W, Almasri J, Barrionuevo P, Alsawas M, Wang Z, Haymond MW, Brown RJ, Murad MH
J Clin Endocrinol Metab 2017 Feb 1;102(2):363-374. doi: 10.1210/jc.2016-2271. PMID: 27967300Free PMC Article
Seip M, Trygstad O
Acta Paediatr Suppl 1996 Jun;413:2-28. doi: 10.1111/j.1651-2227.1996.tb14262.x. PMID: 8783769

Recent systematic reviews

Gupta N, Asi N, Farah W, Almasri J, Barrionuevo P, Alsawas M, Wang Z, Haymond MW, Brown RJ, Murad MH
J Clin Endocrinol Metab 2017 Feb 1;102(2):363-374. doi: 10.1210/jc.2016-2271. PMID: 27967300Free PMC Article
Sivakumar T, Mechanic O, Fehmie DA, Paul B
HIV Med 2011 Sep;12(8):453-62. Epub 2011 Jan 25 doi: 10.1111/j.1468-1293.2010.00906.x. PMID: 21265979

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...